HLS Hls Therapeutics

NOT FOR RELEASE IN THE UNITED STATES OR TO U.S. NEWS WIRE SERVICES 

Eurocontrol Technics Inc. (TSX VENTURE:EUO) ("Eurocontol" or the "Company"), a
Canadian public company specializing in the acquisition, development and
commercialization of innovative energy security, authentication and verification
technologies, is pleased to announce that the shareholders of Eurocontrol have
approved the proposed acquisition of all of the issued and outstanding shares of
Athlone Global Security Inc. ("AGS") in exchange for common shares and warrants
of the Company (the "Transaction") (See Press Releases dated October 19, 2009,
November 30, 2009 and April 5, 2010). 


At the special meeting, disinterested Eurocontrol shareholders, holding
approximately 21% of the issued and outstanding shares of Eurocontrol voted with
more than 99% of the votes cast being voted FOR the Transaction. Completion of
the Transaction remains subject to the required regulatory approvals, including
the approval of the TSX Venture Exchange. Eurocontrol intends to close the
Transaction in the coming weeks. The combined company will be renamed Athlone
Global Solutions Inc. and its common shares will trade on the TSX Venture
Exchange under the symbol "AGH". 


In addition, the Company is pleased to announce it has completed the first
tranche of its previously announced non-brokered private placement financing of
special warrants (the "Special Warrants") at a price of $0.30 per Special
Warrant for gross proceeds in the amount of $880,000. Each Special Warrant
entitles the holder to acquire one unit of the Company (a "Unit") on the deemed
exercise of the Special Warrant. Each Unit will consist of one common share of
the Company (a "Unit Share") and one-half of one common share purchase warrant
of the Company (each whole warrant a "Warrant"). Each Warrant will entitle the
holder thereof to acquire one common share of the Company at an exercise price
of $0.40 for a period of 12 months following the Closing Date (as hereinafter
defined) and at an exercise price of $0.50 for a period of 24 months following
the Closing Date, subject to adjustment in certain events. The Special Warrants
will be deemed to be exercised (for no additional consideration) on the earlier
of: (a) the date that is four months and a day following the Closing Date, and
(b) the fifth business day after the Company completes the Transaction. The
Special Warrants (and any Unit Shares and Warrants issued on exercise thereof)
are subject to regulatory hold period which will expire on August 30, 2010. In
connection with the private placement financing the Company will issue a
finder's fee to Kingsdale Capital (the "Finder") in the amount of $10,800 and
shall issue the Finder compensation warrants to acquire 36,000 Units of the
Company at an exercise price of $0.30 until April 29, 2011.


Purchasers of the Special Warrants are not entitled to receive additional
compensation warrants of the Company issuable to shareholders of record in
connection with the Transaction and such purchasers were not entitled to vote at
the special meeting of shareholders with respect to the Transaction.


The Company is confident that the closing of the private placement will satisfy
the concurrent financing condition of the TSX Venture Exchange with respect to
the Transaction and certain minimum listing requirements imposed by the TSX
Venture Exchange.


About Eurocontrol Technics Inc.

Eurocontrol Technics Inc. through its wholly owned subsidiary Global Fluids
International S.A. ("GFI") is one of the world's pioneers in developing and
implementing innovative molecular marking systems for the oil industry. Through
its proprietary Petromark(TM) integral system, GFI has developed a 4-part
solution consisting of a molecular marker, injection, monitoring and control
components. Such oil industry cost realities along with GFI's 5-year R&D efforts
to create its industry-leading marking solutions, along with access to capital
provided by Eurocontrol Technics Inc. allows management to pursue numerous
anticipated oil marking opportunities in fiscal 2010 and in years to come.


About Athlone Global Security Inc. 

A pioneer in the Homeland Security marketplace, Athlone Global Security Inc.
focuses on acquiring and investing in emerging growth companies specializing in
the development and distribution of imperative Homeland Security ("HLS") related
solutions. AGS, incorporated pursuant to the laws of the British Virgin Islands,
operates principally from its offices in the U.S.A. and Middle East. AGS is
engaged in the acquisition of technologically oriented, privately owned, and
entrepreneurially managed HLS companies that have developed unique products that
can be readily adapted in major global markets where there is great demand for
these products in the global war on terrorism. AGS' primary focus in sourcing
its investment and acquisition opportunities is in Israel due to the wide
breadth of opportunities available and the strong team and infrastructure AGS
has already established in Tel Aviv. Due to the unique knowledge and expertise
of counter-terrorism and HLS technologies, Israel has become an attractive
source of emerging HLS technologies for North American and European markets. 


Please visit the Company's web site at www.athloneglobalsecurity.com.

Regulatory Footnotes

Completion of the Transaction is subject to a number of conditions, including
final TSX Venture Exchange approval. The Transaction cannot close until the
required shareholder approval is obtained. There can be no assurance that the
Transaction will be completed as proposed or at all.


Investors are cautioned that, except as disclosed in the Management Information
Circular dated March 29, 2010 prepared by Eurocontrol in connection with the
Transaction, any information released or received with respect to the business
combination may not be accurate or complete and should not be relied upon.
Trading in the securities of Eurocontrol should be considered highly
speculative.


The TSX Venture Exchange has in no way passed upon the merits of the proposed
transaction nor approved or disapproved of the contents of this news release.


Macquarie Capital Markets Canada Ltd., subject to completion of satisfactory due
diligence, has agreed to act as sponsor to AGS in connection with the
Transaction. An agreement to sponsor should not be construed as any assurance
with respect to the merits of the transaction or the likelihood of completion".
This agreement to sponsor should not be construed as any assurance with respect
to the merits of the proposed Transaction or its likelihood of completion.


This press release shall not constitute an offer to sell or solicitation of an
offer to buy the securities in any jurisdiction. The securities will not be and
have not been registered under the United States Securities Act of 1933 and may
not be offered or sold in the United States absent registration or applicable
exemption from the registration requirements. 


Cautionary Note Regarding Forward-Looking Information This press release
contains "forward-looking information" within the meaning of applicable Canadian
securities legislation. Forward-looking information includes, but is not limited
to, statements with respect to the future financial or operating performance of
each of Eurocontrol and AGS and its projects, statements regarding technological
prospects, statements regarding synergies and financial impact of the proposed
transaction, the terms and conditions of the transaction, the benefits of the
proposed transaction, costs of and capital for projects, expenditures, timing of
future technological developments, requirements for additional capital,
government regulation of industrial operations, environmental risks, title
disputes or claims, limitations of insurance coverage and the timing and
possible outcome of pending litigation and regulatory matters. Generally,
forward-looking information can be identified by the use of forward-looking
terminology such as "plans", "expects" or "does not expect", "is expected",
"budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or
"does not anticipate", or "believes", or variations of such words and phrases or
state that certain actions, events or results "may", "could", "would", "might"
or "will be taken", "occur" or "be achieved". 

Forward-looking information is subject to known and unknown risks, uncertainties
and other factors that may cause the actual results, level of activity,
performance or achievements of the Company (and the company resulting from the
successful completion of the proposed transaction) to be materially different
from those expressed or implied by such forward-looking information, including
but not limited to: general business, economic, competitive, political and
social uncertainties; the actual results of current exploration activities;
delay or failure to receive board or regulatory approvals; timing and
availability of external financing on acceptable terms; the business of AGS and
Eurocontrol and AGS not being integrated successfully or such integration
proving more difficult, time consuming or costly than expected; not realizing on
the potential benefits of the proposed transaction; conclusions of economic
evaluations; changes in project parameters as plans continue to be refined;
failure of plant, equipment or processes to operate as anticipated; accidents,
labour disputes and other risks of the industrial industry; and, delays in
obtaining governmental approvals or required financing or in the completion of
activities. Although the Company has attempted to identify important factors
that could cause actual results to differ materially from those contained in
forward-looking information, there may be other factors that cause results not
to be as anticipated, estimated or intended. There can be no assurance that such
information will prove to be accurate, as actual results and future events could
differ materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward-looking information.
Eurocontrol and AGS do not undertake to update any forward-looking information,
except in accordance with applicable securities laws.

Hls Therapeutics (TSXV:HLS)
Historical Stock Chart
From Oct 2024 to Nov 2024

Hls Therapeutics (TSXV:HLS)
Historical Stock Chart
From Nov 2023 to Nov 2024